Biotech · Private company
ImmuPharma
Track this companyFree. Adds ImmuPharma to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- IPP-201101Phase 3 · Lupus Erythematosus, SystemicClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusPHASE3 · COMPLETED · started Feb 27, 2018ClinicalTrials.gov NCT03427151 · fetched Nov 12, 2026
- A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusPHASE3 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02504645 · fetched Nov 12, 2026